Hanmi Science has been granted a patent for a compound that can bind to a globulin Fc region or a physiologically active polypeptide. The invention also includes methods for preparing polypeptide conjugates and physiologically active polypeptide conjugates. GlobalData’s report on Hanmi Science gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Premium Insights Hanmi Science Co Ltd - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Hanmi Science, Hormone-based therapies for metabolic disorders was a key innovation area identified from patents. Hanmi Science's grant share as of February 2024 was 42%. Grant share is based on the ratio of number of grants to total number of patents.

Compound for binding to globulin fc region or polypeptide

Source: United States Patent and Trademark Office (USPTO). Credit: Hanmi Science Co Ltd

A recently granted patent (Publication Number: US11925691B2) discloses a compound selected from a specific formula, stereoisomers, solvates, and pharmaceutically acceptable salts. The compound falls under Formula 1a, with various options listed under Formulae 2a to 2n. This patent aims to protect the use of these compounds in pharmaceutical applications.

Furthermore, the patent also covers a method for preparing the compound mentioned in the claims. The method involves introducing an amino group at one end of polyethylene glycol, attaching R2 at the other end through an amide bond, and introducing an aliphatic hydrocarbon group with an aldehyde group at the opposite end. This method ensures the synthesis of the desired compound for potential pharmaceutical use. This patent provides a detailed process for the preparation of the compound, ensuring its reproducibility and potential application in the pharmaceutical industry.

To know more about GlobalData’s detailed insights on Hanmi Science, buy the report here.

This content was updated on 25 January 2024

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies